Pathological evaluation of the pathogenesis of diabetes mellitus and diabetic peripheral neuropathy.
Hiroki MizukamiPublished in: Pathology international (2024)
Currently, there are more than 10 million patients with diabetes mellitus in Japan. Therefore, the need to explore the pathogenesis of diabetes and the complications leading to its cure is becoming increasingly urgent. Pathological examination of pancreatic tissues from patients with type 2 diabetes reveals a decrease in the volume of beta cells because of a combination of various stresses. In human type 2 diabetes, islet amyloid deposition is a unique pathological change characterized by proinflammatory macrophage (M1) infiltration into the islets. The pathological changes in the pancreas with islet amyloid were different according to clinical factors, which suggests that type 2 diabetes can be further subclassified based on islet pathology. On the other hand, diabetic peripheral neuropathy is the most frequent diabetic complication. In early diabetic peripheral neuropathy, M1 infiltration in the sciatic nerve evokes oxidative stress or attenuates retrograde axonal transport, as clearly demonstrated by in vitro live imaging. Furthermore, islet parasympathetic nerve density and beta cell volume were inversely correlated in type 2 diabetic Goto-Kakizaki rats, suggesting that diabetic peripheral neuropathy itself may contribute to the decrease in beta cell volume. These findings suggest that the pathogenesis of diabetes mellitus and diabetic peripheral neuropathy may be interrelated.
Keyphrases
- type diabetes
- glycemic control
- wound healing
- oxidative stress
- cardiovascular disease
- insulin resistance
- gene expression
- high resolution
- spinal cord injury
- adipose tissue
- endothelial cells
- cell therapy
- mass spectrometry
- blood pressure
- risk factors
- metabolic syndrome
- cell proliferation
- induced pluripotent stem cells
- weight loss
- endoplasmic reticulum stress